0001411690-22-000023.txt : 20220817
0001411690-22-000023.hdr.sgml : 20220817
20220817175528
ACCESSION NUMBER: 0001411690-22-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linney Yvonne
CENTRAL INDEX KEY: 0001810930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38613
FILM NUMBER: 221175615
MAIL ADDRESS:
STREET 1: C/O BIONANO GENOMICS, INC.
STREET 2: 9540 TOWNE CENTRE DRIVE, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bionano Genomics, Inc.
CENTRAL INDEX KEY: 0001411690
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 261756290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 888-7600
MAIL ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Bionano Genomics, Inc
DATE OF NAME CHANGE: 20190308
FORMER COMPANY:
FORMER CONFORMED NAME: BioNano Genomics, Inc
DATE OF NAME CHANGE: 20120703
FORMER COMPANY:
FORMER CONFORMED NAME: BioNanomatrix Inc
DATE OF NAME CHANGE: 20070906
4
1
wf-form4_166077329973010.xml
FORM 4
X0306
4
2022-08-15
0
0001411690
Bionano Genomics, Inc.
BNGO
0001810930
Linney Yvonne
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2022-08-15
4
M
0
20000
0.38
A
20000
D
Common Stock
2022-08-15
4
S
0
20000
3.6201
D
0
D
Stock Option (Right to Buy)
0.38
2022-08-15
4
M
0
20000
0
D
2030-05-04
Common Stock
20000.0
60923
D
The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
/s/ R. Erik Holmlin, Attorney-in-Fact
2022-08-17